Susan Silbermann
Director/Board Member at LIANBIO
Net worth: 5 292 $ as of 2024-04-29
Susan Silbermann active positions
Companies | Position | Start | End |
---|---|---|---|
LIANBIO | Director/Board Member | 2021-10-11 | - |
Independent Dir/Board Member | 2021-10-11 | - | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Director/Board Member | - | - |
Meet The Writers, Inc. | Director/Board Member | - | - |
Career history of Susan Silbermann
Former positions of Susan Silbermann
Companies | Position | Start | End |
---|---|---|---|
MALLINCKRODT PLC | Director/Board Member | 2022-10-04 | 2023-11-13 |
Independent Dir/Board Member | 2022-10-04 | 2023-11-13 | |
HILLEVAX, INC. | Director/Board Member | 2021-02-28 | 2023-04-17 |
Independent Dir/Board Member | 2021-02-28 | 2023-04-17 | |
PFIZER, INC. | President | - | 2021-04-30 |
Council of the Americas, Inc.
Council of the Americas, Inc. Miscellaneous Commercial ServicesCommercial Services Council of the Americas, Inc. is a non-profit organization, which engages in the management of professional membership organization. It aims to promote economic and social development, open markets, rule of law, and democracy. The firm is composed of companies representing the sectors of banking and finance, consulting services, consumer products, energy and mining, manufacturing, media, technology, and transportation. The company was founded by David Rockefeller Sr. in 1965 and is headquartered in New York, NY. | Director/Board Member | 2011-05-25 | - |
Training of Susan Silbermann
Tufts University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
New York University | Graduate Degree |
Statistics
International
United States | 10 |
Ireland | 2 |
Operational
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
HILLEVAX, INC. | Health Technology |
LIANBIO | Health Technology |
PFIZER, INC. | Health Technology |
MALLINCKRODT PLC | Health Technology |
Private companies | 3 |
---|---|
Council of the Americas, Inc.
Council of the Americas, Inc. Miscellaneous Commercial ServicesCommercial Services Council of the Americas, Inc. is a non-profit organization, which engages in the management of professional membership organization. It aims to promote economic and social development, open markets, rule of law, and democracy. The firm is composed of companies representing the sectors of banking and finance, consulting services, consumer products, energy and mining, manufacturing, media, technology, and transportation. The company was founded by David Rockefeller Sr. in 1965 and is headquartered in New York, NY. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Meet The Writers, Inc. |
- Stock Market
- Insiders
- Susan Silbermann
- Experience